Syschem India Ltd vs Vaishali Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Syschem (India) Ltd is ₹ 51.78 as of 30 Apr 15:30 . The P/E Ratio of Syschem (India) Ltd changed from 33.7 on March 2023 to 332.4 on March 2025 . This represents a CAGR of 114.46% over 3 yearsThe P/E Ratio of Vaishali Pharma Ltd changed from 32.9 on March 2021 to 209.7 on March 2025 . This represents a CAGR of 44.84% over 5 years The Market Cap of Syschem (India) Ltd changed from ₹ 16.16 crore on March 2021 to ₹ 159.08 crore on March 2025 . This represents a CAGR of 57.99% over 5 yearsThe Market Cap of Vaishali Pharma Ltd changed from ₹ 171.9 crore on March 2021 to ₹ 134.85 crore on March 2025 . This represents a CAGR of -4.74% over 5 years The Revenue of Syschem (India) Ltd is ₹ 0 crore as of Jun '25 .The Revenue of Vaishali Pharma Ltd is ₹ 24.59 crore as of Jun '25 . The EBITDA of Syschem (India) Ltd is ₹ 0 crore as of Jun '25 .The EBITDA of Vaishali Pharma Ltd is ₹ 2.21 crore as of Jun '25 . The Net Profit of Syschem (India) Ltd is ₹ 0 crore as of Jun '25 .The Net Profit of Vaishali Pharma Ltd is ₹ 1.28 crore as of Jun '25 . The Dividend Payout of Syschem (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Syschem (India) Ltd

Syschem (India) Limited, formerly known as Anil Pesticides Limited was incorporated on 31 December, 1993.
The name of the Company was changed from Anil Pesticides Limited to Syschem (India) Limited on February 17, 2003.
Company is engaged in the business of manufacturing of API / Intermediates.
It has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt.
Panchkula (Haryana). In 1996 the company went for launching new product called Monocrotophos and production was commissioned in 1998. The company expanded the installed capacity of Dichlorvos by 400 TPM in 2000. The company introduced new products namely Deta,DETC and Ethion in 2001.

About Vaishali Pharma Ltd

Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
M/s.
Vaishali Pharmachem through Business Assignment agreement.
Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

FAQs for the comparison of Syschem (India) Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, Syschem (India) Ltd or Vaishali Pharma Ltd?

Market cap of Syschem (India) Ltd is 253 Cr while Market cap of Vaishali Pharma Ltd is 99 Cr

What are the key factors driving the stock performance of Syschem (India) Ltd and Vaishali Pharma Ltd?

The stock performance of Syschem (India) Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Syschem (India) Ltd and Vaishali Pharma Ltd?

As of May 4, 2026, the Syschem (India) Ltd stock price is INR ₹51.78. On the other hand, Vaishali Pharma Ltd stock price is INR ₹7.61.

How do dividend payouts of Syschem (India) Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of Syschem (India) Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.